scholarly journals Effects of cellulase, carnitine and fish supplementations on lipid and fatty acid levels of Muscovy duck eggs

2021 ◽  
Vol 902 (1) ◽  
pp. 012002
Author(s):  
Sudibya ◽  
E Rusdiyana ◽  
E Handayanta
Keyword(s):  
Fatty Acid ◽  
Fish Oil ◽  
Unsaturated Fatty Acids ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Basal Diet ◽  
Cholesterol Content ◽  
Muscovy Duck ◽  
Cellulase Enzyme ◽  
Fish Oil Supplementation

Abstract The research aimed to investigate the effect of cellulase, carnitine and Lemuru fish oil supplementation on lipid and fatty acid contents of Muscovy duck eggs. A total of 120 Muscovy duck was allocated randomly to 4 dietary treatments. The basal diet consisted of corn, rice bran and layer concentrate, defined as P1. The remaining treatments were basal diet + 0.1% cellulase enzyme (P2), basal diet + 0.1% cellulase enzyme + 40 ppm L carnitine (P3), basal diet + 0.1% cellulase enzyme + 40ppm L-carnitine + 4% Lemuru fish oil (P4). Result shows supplementation of cellulase enzyme did not influence lipid, cholesterol, and fatty acid contents in eggs resulted, while supplementation of carnitine decreased cholesterol content (P<0.01) without affecting lipid and fatty acid contents. Furthermore, supplementation of Lemuru fish oil in diet containing cellulase enzyme and carnitine enhanced lipid, high-density lipoprotein, and unsaturated fatty acid contents in the eggs (P<0.01). Accordingly, supplementation of Lemuru fish oil decreased low-density lipoprotein, cholesterol, and saturated fatty acid contents (P<0.01). It is concluded that supplementation of carnitine and fish oil in the diet produced Muscovy duck eggs with considerably high unsaturated fatty acids and low cholesterol contents.

159 Changes in fatty acid profile in plasma and very low density lipoprotein lipids after fish oil supplementation

1997 ◽  
Vol 25 (4) ◽  
pp. S687-S687
Author(s):  
CHI DING ◽  
PAOLO BORDIN ◽  
ROBERT M. GRAY ◽  
PETER A. BANNISTER ◽  
DESMOND G. JOHNSTON ◽  
...  
Keyword(s):  
Fatty Acid ◽  
Fish Oil ◽  
Fatty Acid Profile ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Very Low Density Lipoprotein ◽  
Low Density ◽  
Lipoprotein Lipids ◽  
Fish Oil Supplementation

scholarly journals Effect of atorvastatin and rosuvasta tin on the fatty acid spectrum of lymphocyte membranes in patients with unstable angina

2020 ◽  
pp. 92-95
Author(s):  
T.V. Bogdan ◽  
Keyword(s):  
Cardiovascular Disease ◽  
Fatty Acids ◽  
Fatty Acid ◽  
Unstable Angina ◽  
Unsaturated Fatty Acids ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Membrane Phospholipids ◽  
Stabilization Of Membranes ◽  
Dynamic Structures

Numerous studies have demonstrated the superiority of rosuvastatin over other statins in the treatment of cardiovascular disease. It has been proven that rosuvastatin is more effectively lowers low-density lipoprotein cholesterol in patients with cardiovascular disease than other members of this drug group. Despite the known mechanisms of action of statins on blood lipids, their effective use in patients with cardiovascular disease, as well as side effects, the influence of these drugs on the fatty acid spectrum of lymphocyte (LC) membrane phospholipids in patients with ischemic heart disease remains unexplored. The results of the studies cited in the article indicate that, in patients with unstable angina who received the therapy that included rosuvastatin, unlike patients receiving the basic treatment with atorvastatin, the relative phosphate lipid contents of palmitic, stearic, and stearin arachidonic polyunsaturated fatty acids and the amount of unsaturated fatty acids are normalized, which testifies to the stabilization of membranes as dynamic structures.

Elevation of Low-Density Lipoprotein Cholesterol Concentration with Over-the-Counter Fish Oil Supplementation

2007 ◽  
Vol 41 (7-8) ◽  
pp. 1296-1300 ◽  
Author(s):  
Jennifer M Malinowski ◽  
Kimberly Metka
Keyword(s):  
Fish Oil ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Lipoprotein Cholesterol ◽  
Cholesterol Concentration ◽  
Low Density ◽  
Low Density Lipoprotein Cholesterol ◽  
Over The Counter ◽  
Epa And Dha ◽  
Fish Oil Supplementation

Objective: To report a case of elevated low-density lipoprotein cholesterol (LDL-C) concentration in a patient taking fish oil supplements for hypertriglyceridemia. Case Summary: A 63-year-old white woman had been taking 2.7 g of eico-sapentaenotc acid (EPA) and docosahexaenoic acid (DHA) daily in 9 g of over-the-counter (OTC) fish oil capsules for triglyceride lowering. Prior to the adverse event, she had baseline fasting triglyceride (TG) and LDL-C concentrations of 278 mg/dL and 106 mg/dL, respectively. After 6 weeks of treatment with fish oil, fasting TG levels decreased by 47.5% (-132 mg/dL) and the LDL-C increased by 75% (+80 mg/dL). Discontinuation of therapy for 6 weeks resulted in TG returning to high concentrations (334 mg/dL; +56 mg/dL change from baseline) and LDL-C decreasing toward baseline (143 mg/dL; +37 mg/dL change from baseline). Discussion: Fish oil, an omega-3 polyunsaturated fatty acid, consists of EPA and DHA. EPA and DHA are thought to inhibit the synthesis of triglycerides in the liver. Type IV dyslipidemic patients may develop increased LDL-C levels while taking fish oil to lower triglycerides due to possible down-regulation of the LDL-C receptor in hepatic cells and formation of larger LDL particles. Use of the Naranjo probability scale indicates a probable relationship between elevations in LDL-C from baseline and initiation of fish oil treatment for hypertriglyceridemia. It is unknown whether any component within this particular product could have contributed to such an unusual elevation in LDL-C. Conclusions: This case documents a much higher LDL-C elevation associated with OTC fish oil supplementation than has been previously identified in the literature. Healthcare providers should be advised that LDL-C levels may increase with use of OTC fish oil and should monitor patients periodically for such elevations. The significance of this Increase on clinical outcomes is not known.

scholarly journals Evaluation of Lipid Profiles and the Use of Omega-3 Essential Fatty Acid in Professional Football Players

2009 ◽  
Vol 1 (1) ◽  
pp. 21-30 ◽  
Author(s):  
Anthony Yates ◽  
John Norwig ◽  
Joseph C. Maroon ◽  
Jeffrey Bost ◽  
James P. Bradley ◽  
...  
Keyword(s):  
Docosahexaenoic Acid ◽  
Eicosapentaenoic Acid ◽  
Fish Oil ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Football Players ◽  
Low Density ◽  
Professional Football ◽  
Omega 3 ◽  
Fish Oil Supplementation

Background: Recent research showed 82% of 233 retired National Football League players under age 50 had abnormal narrowing and blockages in arteries compared to the general population of the same age. It has been suggested that early screening and intervention in this at-risk population be a priority. Hypothesis: Omega-3 essential fatty acid has been shown to improve cardiovascular lipid risk factors and should improve lipid profiles in professional football players to help reduce their recently shown accelerated risk of developing cardiovascular disease. Methods: A total of 36 active national football players were randomly assigned to 2 groups: the first group (n = 20) was provided fish oil capsules (2200 mg of mixed docosahexaenoic acid and eicosapentaenoic acid and 360 mg of other omega-3s), and the second group (n = 16) served as controls during a 60-day trial. Vertical Auto Profile cholesterol tests directly measuring serum low-density lipoprotein, high-density lipoprotein, and other subfractions were performed. Compliance, side effects, and seafood consumption data were also collected. Baseline, midpoint, and poststudy blood work measured plasma docosahexaenoic acid and eicosapentaenoic acid. Results: Treatment increased high-density lipoprotein (average percent change: +25.96, control +14.16), decreased triglycerides treatment (–8.06, control +43.98), very low-density lipoprotein treatment (–13.98, control +23.18), intermediate density lipoprotein (–27.58, control +12.07), remnant lipoproteins (–23.86, control +8.33), and very low-density lipoprotein-3 (–17.10, control +7.77). An average increase of 106.67% for docosahexaenoic acid and 365.82% for eicosapentaenoic acid compared to control was also shown. Conclusion: Omega-3 supplementation significantly improved the lipid profile of active players randomized to treatment. These results suggest that fish oil supplementation is an effective way to increase eicosapentaenoic acid and docosahexaenoic acid levels in plasma and should be considered as a method to improve modifiable cardiovascular risk lipid factors in professional football players. Clinical Relevance: A prospective study examining the effects of 60 days of a highly purified fish oil supplementation in professional football players.

scholarly journals Effects ofn-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects

1992 ◽  
Vol 68 (3) ◽  
pp. 655-666 ◽  
Author(s):  
Christine M. Williams ◽  
F. Moore ◽  
L. Morgan ◽  
J. Wright
Keyword(s):  
Fatty Acids ◽  
Fatty Acid ◽  
Fish Oil ◽  
Test Meal ◽  
Density Lipoprotein ◽  
Early Morning ◽  
Fish Oils ◽  
Fatty Acid Supplementation ◽  
Fish Oil Supplementation ◽  
Postprandial Triacylglycerol

The present study reports results from two investigations to determine effects of a 6-week period of moderaten-3 fatty acid supplementation (2.7 g/d) on fasting and on postprandial triacylglycerol and metabolic hormone concentrations in response to standard test meals. In the first study postprandial responses were followed for 210 min after an early morning test meal challenge; in the second study responses to an evening test meal were followed during the evening and overnight for a total period of 12 h. In both studies postprandial triacylglycerol responses to the test meals were significantly reduced after compared with before fish-oil supplementation. In the second study the triacylglycerol peak response seen between 200 and 400 min in subjects studied before supplementation with fish oils was almost completely absent in the same subjects after 6 weeks ofn-3 fatty acid supplementation. Analysis of fasting concentrations of metabolites and hormones was carried out on the combined data from the two studies. There were no significant differences in total, low-density-lipoprotein- or high-density-lipoprotein-cholesterol concentrations during fish-oil supplementation, although there was considerable individual variation in cholesterol responses to the supplement. Concentrations of Apo-B and Apo-A1 were unchanged during supplementation with fish oils. Fasting and early morning postprandial GIP concentrations were lower in subjects taking fish oils, possibly due to acute effects of fish-oil capsules taken on the evening before the studies. In both studies fasting insulin and glucose and postprandial insulin concentrations remained unchanged following fish-oil supplementation. The results do not support the view that triacylglycerol-lowering effects ofn-3 fatty acids are due to modulation of insulin secretion mediated via the enteroinsular axis. Further studies are required to determine the precise mechanism by which fish oils reduce both fasting and postprandial triacylglycerol concentrations.

Effect of fish-oil supplementation on levels of (n-3) poly-unsaturated fatty acids in the lipoprotein fractions of bovine plasma

2001 ◽  
Vol 73 (3) ◽  
pp. 523-531 ◽  
Author(s):  
N.W. Offer ◽  
B.K. Speake ◽  
J. Dixon ◽  
M. Marsden
Keyword(s):  
Fatty Acids ◽  
Sugar Beet ◽  
Fish Oil ◽  
Milk Fat ◽  
Unsaturated Fatty Acids ◽  
Density Lipoprotein ◽  
Control Group ◽  
Triglyceride Fraction ◽  
Fish Oil Supplementation ◽  
Long Chain

AbstractEight mid-lactation Holstein-Friesian dairy cows were used in an experiment to investigate whether poor transfer to milk of (n-3) long chain (≥C20) poly-unsaturated fatty acids (n-3 LCPUFA), from diets containing fish oil, is related to their mode of transport in plasma lipoproteins. The cows were split into two groups of four, each of which was housed with 24 other cows which did not provide blood data in this experiment. All cows received a basal diet ad libitum consisting of (kg/t dry matter) silage (539), grain distillers’ grains (148), rolled barley (248) and soya (65). All cows also received a mid-day meal of 2·76 kg per cow per day of molassed sugar-beet shreds. The control group (C) received no oil supplement but those in the treatment group (F) received 300 g per cow per day of fish oil absorbed onto the sugar-beet shreds. Fish oil inclusion progressively depressed milk fat concentration of the four cows from each group over the 3 weeks of the experiment so that levels were approximately 20 g/kg lower for cows in treatment F than for those in C (P < 0·05). Mean concentrations over all cows of the long-chain (≥C20, n-3) poly-unsaturated fatty acids in milk fat (g/100 g) were 0·12 and 0·54 for treatments C and F respectively, whilst corresponding output in milk (g/day) increased from 116 to 3·91, an average efficiency of transfer of 4·6%. The fatty acid compositions of the lipoproteins were measured in plasma samples from the four cows from each group after 3 weeks on the experimental diets The proportions (g/100 g fatty acids) of C20: 5 (n-3) in cholesteryl (CE) and phospholipid (PL) of high-density lipoprotein (HDL) in the plasma were respectively increased from 0·97 to 4·39 (P < 0·05) and from 1·15 to 4·74 (P < 0·01) by the fish-oil supplementation. For C22: 6 (n-3), the proportions in CE and PL of HDL respectively increased (P < 0·001) from 0·02 to 0·23 and from 0·16 to 2·18 as a result of the supplementation. The mean proportions (g/100 g fatty acids) of C20: 5 (n-3) and C22: 6 (n-3) in the triglyceride fraction of very low-density lipoprotein were 1·05 and 2·3 respectively and were not significantly altered by fish-oil supplementation (P > 0·05). It is suggested that the low transfer efficiency of (n-3) LCPUFA to the milk is partly due to their transport in the plasma largely as components of HDL lipids which are unavailable to the mammary gland.

n − 3 Fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids

2006 ◽  
Vol 111 (4) ◽  
pp. 289-294 ◽  
Author(s):  
Anne E. Barden ◽  
Janet A. Dunstan ◽  
Lawrence J. Beilin ◽  
Susan L. Prescott ◽  
Trevor A. Mori
Keyword(s):  
Blood Pressure ◽  
Fatty Acid ◽  
Fish Oil ◽  
Olive Oil ◽  
Total Cholesterol ◽  
Allergic Disease ◽  
Density Lipoprotein ◽  
Lipid Levels ◽  
Fatty Acid Supplementation ◽  
Fish Oil Supplementation

n−3 Fatty acids derived from fish oil reduce plasma triacylglycerols (triglycerides) and increase HDL-C (high-density lipoprotein cholesterol); however, the effect of n−3 fatty acid supplementation during pregnancy, a hyperlipidaemic state, remains unknown. We took the opportunity to investigate maternal lipid levels and blood pressure during and after pregnancy, and fetal lipid levels at birth, in a study that aimed primarily to examine the effect of fish oil supplementation during pregnancy on immune function in infants born to women with allergic disease. Eighty-three pregnant women who had allergic disease, but were otherwise healthy, completed the study. They were randomly allocated to receive fish oil or olive oil capsules, taken as 4 g/day, from 20 weeks of pregnancy until delivery. Compared with olive oil, fish oil supplementation did not alter triacylglycerols, total cholesterol, LDL-C (low-density lipoprotein cholesterol) or HDL-C during or after pregnancy. There was also no effect of fish oil on cord blood triacylglycerols, total cholesterol, LDL-C or HDL-C. Fish oil supplementation during pregnancy did not alter maternal blood pressure during or after pregnancy. The effects of fish oil on lipids and blood pressure in non-pregnant individuals appear to be lost when it is administered during pregnancy.

Sign in / Sign up

Export Citation Format

Share Document